{"id":"https://openalex.org/W2159500569","doi":"https://doi.org/10.1677/joe-06-0018","title":"Dual-acting peptide with prolonged glucagon-like peptide-1 receptor agonist and glucagon receptor antagonist activity for the treatment of type 2 diabetes","display_name":"Dual-acting peptide with prolonged glucagon-like peptide-1 receptor agonist and glucagon receptor antagonist activity for the treatment of type 2 diabetes","publication_year":2007,"publication_date":"2007-02-01","ids":{"openalex":"https://openalex.org/W2159500569","doi":"https://doi.org/10.1677/joe-06-0018","mag":"2159500569","pmid":"https://pubmed.ncbi.nlm.nih.gov/17283237"},"language":"en","primary_location":{"id":"doi:10.1677/joe-06-0018","doi":"https://doi.org/10.1677/joe-06-0018","is_oa":true,"landing_page_url":"https://doi.org/10.1677/joe-06-0018","pdf_url":"https://joe.bioscientifica.com/downloadpdf/journals/joe/192/2/1920371.pdf","source":{"id":"https://openalex.org/S34842069","display_name":"Journal of Endocrinology","issn_l":"0022-0795","issn":["0022-0795","1479-6805"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319937","host_organization_name":"Bioscientifica","host_organization_lineage":["https://openalex.org/P4310319937"],"host_organization_lineage_names":["Bioscientifica"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Endocrinology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://joe.bioscientifica.com/downloadpdf/journals/joe/192/2/1920371.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110358113","display_name":"Thomas H. Claus","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thomas H Claus","raw_affiliation_strings":["Bayer HealthCare, Biotechnology, 800 Dwight Way, Berkeley, CA 94701, USA","Bayer HealthCare, Pharmaceuticals, Department of Metabolic Disease Research, 400 Morgan Lane, West Haven, Connecticut 06516 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer HealthCare, Biotechnology, 800 Dwight Way, Berkeley, CA 94701, USA","institution_ids":[]},{"raw_affiliation_string":"Bayer HealthCare, Pharmaceuticals, Department of Metabolic Disease Research, 400 Morgan Lane, West Haven, Connecticut 06516 USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076375328","display_name":"Clark Q. Pan","orcid":"https://orcid.org/0000-0001-5110-1803","observed_orcids":["https://orcid.org/0000-0001-5110-1803"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Clark Q Pan","raw_affiliation_strings":["Bayer HealthCare, Biotechnology, 800 Dwight Way, Berkeley, California 94701, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer HealthCare, Biotechnology, 800 Dwight Way, Berkeley, California 94701, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108364010","display_name":"Joanne M. Buxton","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joanne M Buxton","raw_affiliation_strings":["Bayer HealthCare, Pharmaceuticals, Department of Metabolic Disease Research, 400 Morgan Lane, West Haven, Connecticut 06516 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer HealthCare, Pharmaceuticals, Department of Metabolic Disease Research, 400 Morgan Lane, West Haven, Connecticut 06516 USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101560260","display_name":"Ling Yang","orcid":"https://orcid.org/0000-0002-5506-7021","observed_orcids":["https://orcid.org/0000-0002-5506-7021","https://orcid.org/0000-0003-1540-4385"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ling Yang","raw_affiliation_strings":["Bayer HealthCare, Pharmaceuticals, Department of Metabolic Disease Research, 400 Morgan Lane, West Haven, Connecticut 06516 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer HealthCare, Pharmaceuticals, Department of Metabolic Disease Research, 400 Morgan Lane, West Haven, Connecticut 06516 USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050413473","display_name":"Jennifer C Reynolds","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jennifer C Reynolds","raw_affiliation_strings":["Bayer HealthCare, Pharmaceuticals, Department of Metabolic Disease Research, 400 Morgan Lane, West Haven, Connecticut 06516 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer HealthCare, Pharmaceuticals, Department of Metabolic Disease Research, 400 Morgan Lane, West Haven, Connecticut 06516 USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012866293","display_name":"Nicole Barucci","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nicole Barucci","raw_affiliation_strings":["Bayer HealthCare, Pharmaceuticals, Department of Metabolic Disease Research, 400 Morgan Lane, West Haven, Connecticut 06516 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer HealthCare, Pharmaceuticals, Department of Metabolic Disease Research, 400 Morgan Lane, West Haven, Connecticut 06516 USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083142154","display_name":"Michael G. Burns","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael Burns","raw_affiliation_strings":["Bayer HealthCare, Pharmaceuticals, Department of Metabolic Disease Research, 400 Morgan Lane, West Haven, Connecticut 06516 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer HealthCare, Pharmaceuticals, Department of Metabolic Disease Research, 400 Morgan Lane, West Haven, Connecticut 06516 USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111742491","display_name":"Astrid A. Ortiz","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Astrid A Ortiz","raw_affiliation_strings":["Bayer HealthCare, Biotechnology, 800 Dwight Way, Berkeley, California 94701, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer HealthCare, Biotechnology, 800 Dwight Way, Berkeley, California 94701, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067346961","display_name":"Steve Roczniak","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Steve Roczniak","raw_affiliation_strings":["Bayer HealthCare, Biotechnology, 800 Dwight Way, Berkeley, California 94701, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer HealthCare, Biotechnology, 800 Dwight Way, Berkeley, California 94701, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114009400","display_name":"James N. Livingston","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James N Livingston","raw_affiliation_strings":["Bayer HealthCare, Pharmaceuticals, Department of Metabolic Disease Research, 400 Morgan Lane, West Haven, Connecticut 06516 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer HealthCare, Pharmaceuticals, Department of Metabolic Disease Research, 400 Morgan Lane, West Haven, Connecticut 06516 USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001532920","display_name":"Kevin B. Clairmont","orcid":"https://orcid.org/0000-0003-4198-2437","observed_orcids":["https://orcid.org/0000-0003-4198-2437"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kevin B Clairmont","raw_affiliation_strings":["Bayer HealthCare, Pharmaceuticals, Department of Metabolic Disease Research, 400 Morgan Lane, West Haven, Connecticut 06516 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer HealthCare, Pharmaceuticals, Department of Metabolic Disease Research, 400 Morgan Lane, West Haven, Connecticut 06516 USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5021660477","display_name":"James Whelan","orcid":"https://orcid.org/0000-0001-5754-025X","observed_orcids":["https://orcid.org/0000-0001-5754-025X"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"James P Whelan","raw_affiliation_strings":["Bayer HealthCare, Pharmaceuticals, Department of Metabolic Disease Research, 400 Morgan Lane, West Haven, Connecticut 06516 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer HealthCare, Pharmaceuticals, Department of Metabolic Disease Research, 400 Morgan Lane, West Haven, Connecticut 06516 USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5021660477"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.0852,"has_fulltext":true,"cited_by_count":46,"citation_normalized_percentile":{"value":0.86855086,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"192","issue":"2","first_page":"371","last_page":"380"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10839","display_name":"Pancreatic function and diabetes","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9549999833106995},{"id":"https://openalex.org/keywords/glucagon-like-peptide-1","display_name":"glucagon-like peptide-1","score":0.8759999871253967},{"id":"https://openalex.org/keywords/glucagon-receptor-antagonists","display_name":"glucagon receptor antagonists","score":0.7850000262260437},{"id":"https://openalex.org/keywords/pegylation","display_name":"PEGylation","score":0.7829999923706055},{"id":"https://openalex.org/keywords/glp-1-receptor-agonism","display_name":"GLP-1 receptor agonism","score":0.7179999947547913},{"id":"https://openalex.org/keywords/glucose-dependent-insulin-secretion","display_name":"glucose-dependent insulin secretion","score":0.6710000038146973},{"id":"https://openalex.org/keywords/hepatic-glucose-production","display_name":"hepatic glucose production","score":0.7670000195503235},{"id":"https://openalex.org/keywords/exendin-9-39","display_name":"exendin-9-39","score":0.875},{"id":"https://openalex.org/keywords/gastrointestinal-motility","display_name":"gastrointestinal motility","score":0.8209999799728394},{"id":"https://openalex.org/keywords/db-db-mice","display_name":"db/db mice","score":0.921999990940094},{"id":"https://openalex.org/keywords/glucose-tolerance","display_name":"glucose tolerance","score":0.4830000102519989}],"concepts":[{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7599843740463257},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.7387263178825378},{"id":"https://openalex.org/C2778563252","wikidata":"https://www.wikidata.org/wiki/Q170617","display_name":"Glucagon","level":3,"score":0.6915597915649414},{"id":"https://openalex.org/C2776398474","wikidata":"https://www.wikidata.org/wiki/Q424611","display_name":"Glucagon-like peptide-1","level":4,"score":0.5807312726974487},{"id":"https://openalex.org/C185280430","wikidata":"https://www.wikidata.org/wiki/Q14909910","display_name":"Glucagon-like peptide 1 receptor","level":4,"score":0.5716356039047241},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.5312426090240479},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.4931640028953552},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.48975419998168945},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.46278032660484314},{"id":"https://openalex.org/C2779149719","wikidata":"https://www.wikidata.org/wiki/Q682252","display_name":"PEGylation","level":3,"score":0.4321708083152771},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.30265289545059204},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2779569625854492},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.23200705647468567},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.22368362545967102},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.09921920299530029},{"id":"https://openalex.org/C2776964284","wikidata":"https://www.wikidata.org/wiki/Q410083","display_name":"Polyethylene glycol","level":2,"score":0.07276356220245361}],"mesh":[{"descriptor_ui":"D000067757","descriptor_name":"Glucagon-Like Peptide-1 Receptor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D003921","descriptor_name":"Diabetes Mellitus, Experimental","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003921","descriptor_name":"Diabetes Mellitus, Experimental","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005769","descriptor_name":"Gastrointestinal Motility","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D005934","descriptor_name":"Glucagon","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005951","descriptor_name":"Glucose Tolerance Test","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008807","descriptor_name":"Mice, Inbred BALB C","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008810","descriptor_name":"Mice, Inbred C57BL","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008817","descriptor_name":"Mice, Mutant Strains","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009765","descriptor_name":"Obesity","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D009765","descriptor_name":"Obesity","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D010446","descriptor_name":"Peptide Fragments","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011092","descriptor_name":"Polyethylene Glycols","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D017208","descriptor_name":"Rats, Wistar","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018027","descriptor_name":"Receptors, Glucagon","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D018027","descriptor_name":"Receptors, Glucagon","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D036341","descriptor_name":"Intercellular Signaling Peptides and Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1677/joe-06-0018","doi":"https://doi.org/10.1677/joe-06-0018","is_oa":true,"landing_page_url":"https://doi.org/10.1677/joe-06-0018","pdf_url":"https://joe.bioscientifica.com/downloadpdf/journals/joe/192/2/1920371.pdf","source":{"id":"https://openalex.org/S34842069","display_name":"Journal of Endocrinology","issn_l":"0022-0795","issn":["0022-0795","1479-6805"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319937","host_organization_name":"Bioscientifica","host_organization_lineage":["https://openalex.org/P4310319937"],"host_organization_lineage_names":["Bioscientifica"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Endocrinology","raw_type":"journal-article"},{"id":"pmid:17283237","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17283237","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of endocrinology","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.489.1812","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.489.1812","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://joe.endocrinology-journals.org/content/192/2/371.full.pdf","raw_type":"text"}],"best_oa_location":{"id":"doi:10.1677/joe-06-0018","doi":"https://doi.org/10.1677/joe-06-0018","is_oa":true,"landing_page_url":"https://doi.org/10.1677/joe-06-0018","pdf_url":"https://joe.bioscientifica.com/downloadpdf/journals/joe/192/2/1920371.pdf","source":{"id":"https://openalex.org/S34842069","display_name":"Journal of Endocrinology","issn_l":"0022-0795","issn":["0022-0795","1479-6805"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319937","host_organization_name":"Bioscientifica","host_organization_lineage":["https://openalex.org/P4310319937"],"host_organization_lineage_names":["Bioscientifica"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Endocrinology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320320303","display_name":"Bayer HealthCare","ror":"https://ror.org/04hmn8g73"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2159500569.pdf","grobid_xml":"https://content.openalex.org/works/W2159500569.grobid-xml"},"referenced_works_count":47,"referenced_works":["https://openalex.org/W1567903119","https://openalex.org/W1965918908","https://openalex.org/W1969932276","https://openalex.org/W1978953702","https://openalex.org/W1980130009","https://openalex.org/W1986085856","https://openalex.org/W1992966015","https://openalex.org/W2000845410","https://openalex.org/W2009642048","https://openalex.org/W2017518223","https://openalex.org/W2022234371","https://openalex.org/W2025162869","https://openalex.org/W2025993954","https://openalex.org/W2027433835","https://openalex.org/W2028707869","https://openalex.org/W2032322539","https://openalex.org/W2036141586","https://openalex.org/W2038876068","https://openalex.org/W2039911916","https://openalex.org/W2046912474","https://openalex.org/W2050046962","https://openalex.org/W2051612875","https://openalex.org/W2062175236","https://openalex.org/W2063715420","https://openalex.org/W2083375813","https://openalex.org/W2093738306","https://openalex.org/W2095995901","https://openalex.org/W2096444181","https://openalex.org/W2101613382","https://openalex.org/W2101718966","https://openalex.org/W2105518878","https://openalex.org/W2115944078","https://openalex.org/W2118889627","https://openalex.org/W2119670027","https://openalex.org/W2124182221","https://openalex.org/W2125036135","https://openalex.org/W2127167047","https://openalex.org/W2140577520","https://openalex.org/W2141362365","https://openalex.org/W2143014102","https://openalex.org/W2143752451","https://openalex.org/W2145124248","https://openalex.org/W2162355702","https://openalex.org/W2168726045","https://openalex.org/W2171472795","https://openalex.org/W4231977748","https://openalex.org/W4241398143"],"related_works":["https://openalex.org/W2115944078","https://openalex.org/W7099568361","https://openalex.org/W2023015892","https://openalex.org/W2605774581","https://openalex.org/W2018790262","https://openalex.org/W2044665523","https://openalex.org/W1989069545","https://openalex.org/W2112746083","https://openalex.org/W4225360009","https://openalex.org/W2403559169"],"abstract_inverted_index":{"Type":[0],"2":[1,182],"diabetes":[2,53],"is":[3,145],"characterized":[4],"by":[5,16],"reduced":[6],"insulin":[7,24,87],"secretion":[8,25],"from":[9,26,34],"the":[10,17,27,35,40,132,135,155,169,191],"pancreas":[11],"and":[12,44,62,88,110,163,189],"overproduction":[13],"of":[14,39,97,118,134,143,152,157],"glucose":[15,32,90,93,105,126],"liver.":[18,36],"Glucagon-like":[19],"peptide-1":[20],"(GLP-1)":[21],"promotes":[22,31],"glucose-dependent":[23],"pancreas,":[28],"while":[29],"glucagon":[30,63,108,113,119],"output":[33],"Taking":[37],"advantage":[38],"homology":[41],"between":[42],"GLP-1":[43,59,98,136,162],"glucagon,":[45],"a":[46,92,107,175],"GLP-1/glucagon":[47],"hybrid":[48],"peptide,":[49,138],"dual-acting":[50,177],"peptide":[51,178],"for":[52],"(DAPD),":[54],"was":[55,74],"identified":[56],"with":[57,161,184],"combined":[58],"receptor":[60,64,99,120],"agonist":[61],"antagonist":[65,137],"activity.":[66],"To":[67],"overcome":[68],"its":[69,164],"short":[70],"plasma":[71],"half-life":[72],"DAPD":[73,84,153],"PEGylated,":[75],"resulting":[76],"in":[77,81,91,115,131,147,186],"dramatically":[78],"prolonged":[79,185],"activity":[80],"vivo.":[82],"PEGylated":[83],"(PEG-DAPD)":[85],"increases":[86],"decreases":[89],"tolerance":[94,127],"test,":[95],"evidence":[96,117],"agonism.":[100],"It":[101],"also":[102,129],"reduces":[103],"blood":[104],"following":[106],"challenge":[109],"elevates":[111],"fasting":[112],"levels":[114],"mice,":[116],"antagonism.":[121],"The":[122],"PEG-DAPD":[123,144,167],"effects":[124],"on":[125],"are":[128],"observed":[130,146,160],"presence":[133],"exendin(9-39).":[139],"An":[140],"antidiabetic":[141],"effect":[142],"db/db":[148],"mice.":[149],"Furthermore,":[150],"PEGylation":[151],"eliminates":[154],"inhibition":[156],"gastrointestinal":[158],"motility":[159],"analogues.":[165],"Thus,":[166],"has":[168],"potential":[170],"to":[171,179],"be":[172],"developed":[173],"as":[174],"novel":[176],"treat":[180],"type":[181],"diabetes,":[183],"vivo":[187],"activity,":[188],"without":[190],"GI":[192],"side-effects.":[193]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":8},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}